StrokeWear: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life.

StrokeWear：一种新型腕部可穿戴传感器系统，可促进偏瘫上肢在家庭日常生活中的使用。

• 批准号: 10552347
• 负责人: Paolo Bonato
• 金额: $ 100.81万
• 依托单位: BIOSENSICS, LLC
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-08 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10552347
• 关键词: Accelerometer; Achievement; Activities of Daily Living; Address; Advanced Development; Affect; Algorithms; Behavior; Behavior Therapy; Behavioral; Bilateral; Chronic; Clinical; Clinical Trials; Collection; Communities; Companions; Computer software; Consultations; Control Groups; Data; Data Storage and Retrieval; Databases; Development; Disasters; Elements; Environment; Feedback; Fostering; Goals; Health Insurance Portability and Accountability Act; Home; Home environment; Hospitals; Human Resources; Impairment; Intervention; Legal patent; Life; Limb structure; Monitor; Motivation; Motor; Motor Activity; Movement; Neuronal Plasticity; Patient Monitoring System; Patients; Pattern; Performance; Phase; Portal System; Randomized Clinical Trials; Recovery; Rehabilitation therapy; Secure; Self Efficacy; Services; Side; Small Business Innovation Research Grant; Stimulus; Stroke; System; Techniques; Technology; Testing; Therapeutic; Time; Training; Upper Extremity; Visit; Work; Wrist; arm; base; behavior change; chronic stroke; commercialization; community setting; design; efficacy testing; experience; flexibility; group intervention; hemiparesis; improved; improved functioning; motor control; motor function recovery; motor recovery; novel; novel strategies; patient engagement; primary endpoint; programs; prototype; remote monitoring; sensor; smartphone Application; stroke survivor; telehealth; treatment as usual; wearable sensor technology; web portal

Abstract Stroke survivors often experience a debilitating loss of motor control typically affecting one side of the body. When performing upper-extremity (UE) movements during activities of daily living (ADLs), stroke survivors naturally favor using the more functional UE, thus leading to restricted use of the hemiparetic UE thereby hindering motor recovery. While therapists use conventional techniques to target the hemiparetic UE during clinical visits, patients receive limited direct training on the use of their hemiparetic UE in their home environment. The lack of therapeutic training in the home environment negatively impacts the recovery of UE motor function. Yet, motor improvements are achievable with sufficient motor practice. Based on this body of evidence, through our completed SBIR Fast-Track study, we developed a patented sensor-based technology, called StrokeWearTM. StrokeWearTM consists of a proprietary software and bilateral wrist-worn sensors to continuously monitor UE movements performed by patients in their home and community environments. The system also generates real- time feedback on the performance of goal directed movements (GDM). The objective of this Phase IIB is to further develop StrokeWearTM for commercialization by enhancing the platform with features that will empower and encourage patients to engage in GDM with their hemiparetic UE in the home and to support expert clinicians to foster increased activity in a telehealth environment. The system promotes behavior changes that optimize UE movement patterns for neuro-recovery. In this project, we will integrate goal setting, self-efficacy, behavioral achievements, and movement feedback into StrokeWearTM. To better engage the users, we will develop a companion smartphone application that will encourage patients to be active in monitoring their progress. Finally, we will develop a web-portal that will allow patients and clinicians to be more engaged and interactive during the rehabilitation program through on-demand goal setting and consultation. We will conduct two 6-month randomized clinical trials to assess the efficacy of this integrated platform in both chronic and subacute stroke survivors. The control group will receive usual care, while the intervention group will receive the StrokeWearTM platform in addition to a motor and behavioral home-based intervention.

抽象的 中风幸存者经常经历令人衰弱的运动控制损失，通常会影响身体的一侧。 在日常生活（ADL）的活动期间执行高超高（UE）运动时，中风幸存者 自然使用功能较强的UE，因此会导致偏瘫UE的限制使用 阻碍运动恢复。治疗师使用常规技术来瞄准偏瘫UE 临床访问，患者在家庭环境中使用偏瘫UE的使用有限的直接培训。 家庭环境中缺乏治疗训练会对UE运动功能的恢复产生负面影响。 但是，通过足够的运动练习可以实现运动改善。基于这个证据，通过 我们完成的SBIR快速轨道研究，我们开发了一种基于专利的传感器技术，称为StrokeWeartM。 StrokeWeartM由专有软件和双侧腕部传感器组成，可连续监视UE 患者在家庭和社区环境中进行的运动。该系统还生成了实地 目标指向动作（GDM）的性能的时间反馈。 该阶段IIB的目的是通过增强商业化进一步开发用于商业化的strokeweartm 平台的功能将授权并鼓励患者与Hemiparetic UE一起参与GDM 房屋并支持专家临床医生，以促进在远程医疗环境中增加活动。系统 促进行为变化，以优化神经恢复的UE运动模式。在这个项目中，我们将 将目标设定，自我效能，行为成就和运动反馈整合到strokeweartm中。到 更好地吸引用户，我们将开发一个伴侣智能手机应用程序，以鼓励患者成为 积极监视他们的进度。最后，我们将开发一个网络门户，将允许患者和临床医生 通过按需目标设定和 咨询。我们将进行两个6个月的随机临床试验，以评估该综合的疗效 慢性和亚急性中风幸存者的平台。对照组将接受常规护理，而 干预小组除了电动机和行为家庭外，还将获得StreokeWeartM平台 干涉。